Innate Pharma IPHA
NASDAQ IPHA
$1.60 -0.10 (-5.88%)
At close: Sep 29, 2026 · 4:00 PM EDT

Innate Pharma (IPHA) FCF Margin (2020 - 2025)

Updated

Innate Pharma (IPHA) reported FCF Margin of -404730.77% for the quarter ended Dec 31, 2025, down 345594.41 percentage points from -59136.36% a year earlier.

Analysis

Innate Pharma (IPHA) FCF Margin (2020 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Innate Pharma posted FCF Margin of -584.29%, down 551.96 percentage points from the prior year.

  • FCF Margin has a five-year change of -511.39 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, FCF Margin came in at -32.33% in the year ended Dec 31, 2024 (+19.92 pp), -52.25% in the year ended Dec 31, 2023 (-19.97 pp), -32.28% in the year ended Dec 31, 2022 (+200.59 pp) and -232.88% in the year ended Dec 31, 2021 (-159.99 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Innate Pharma 159.32 Mn 159.32 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -404,730.77%
Dec 31, 2024 -59,136.36%
Dec 31, 2023 -292,800.00%
Dec 31, 2022 -31.56%
Dec 31, 2020 -7,501.47%
API Access

Innate Pharma FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=IPHA&period=max&api_key=YOUR_API_KEY